Medsider: Learn from Medtech and Healthtech Founders and CEOs

Active
Has guests
Scott Nelson
Categories
Entrepreneurship Business Management Health & Fitness
Audience & Performance Metrics
1.0K - 1.7K listeners Neutral 4.7 rating 68 reviews 199 episodes USA
Monetization Metrics
30s Ad: $35 - $44 60s Ad: $42 - $50 CPM Category: Health & Fitness
Socials metrics & links
No data No data
Podcast Links
Learn from the brightest CEOs in medtech and healthtech. That's our primary goal with Medsider. We unpack the strategies, tactics, and secrets behind the most successful startups. Join tens of thousands of ambitious doers and get access to the top medical device and health technology thought leaders.

Producers, Hosts, and Production Team

No producer information available yet. Click "Find producers" to search for the production team.

Emails, Phones, and Addresses

Contact Page Emails

Emails
Phone Numbers

No phone numbers found.

Addresses

No addresses found.

Form

A contact form is available on this page. You can fill out the form at this link.

General Website Emails

No website emails found.

Externally Sourced Emails

No external emails found.

RSS Emails

Recent Hosts, Guests & Topics

Here's a quick summary of the last 5 episodes on Medsider: Learn from Medtech and Healthtech Founders and CEOs.

Hosts

Medsider Radio Medsider Radio Host

Previous Guests

Randy Pritchard
Randy Pritchard is the CEO of Axena Health, bringing nearly 25 years of healthcare experience to the company. He was most recently the CEO of Pillar Biosciences and has held leadership positions at Roche Diagnostics for 18 years, where he developed significant commercial expertise.
Erica Rogers
Erica Rogers is a leader at Axena Health, serving on its Board of Directors. She previously spent a decade as President and CEO of Silk Road Medical, guiding the company from early clinical trials through its IPO and eventual acquisition by Boston Scientific. Erica is a returning guest to the podcast and has co-founded two medical device companies, held roles at Medicine360, and spent over 12 years at Boston Scientific.
Ryan Rhodes
Ryan Rhodes is the CEO of EDAP TMS, a company that is innovating prostate cancer treatment through its Focal One robotic high-intensity focused ultrasound system, which eliminates the need for surgery or radiation. With over 30 years of experience in market development, Ryan has dedicated two decades to the field of medical robotics. Prior to his role at EDAP, he served as CEO of Restoration Robotics, where he successfully led the company to a merger with Venus Concept. Ryan also spent more than 13 years at Intuitive Surgical, where he established the global Urology franchise, significantly contributing to the adoption of the da Vinci surgical system. His earlier career includes 11 years at Ethicon (Johnson & Johnson) in various roles encompassing sales, marketing, and market development.
Kirk Huntsman
Kirk Huntsman is the CEO of Vivos, a company that commercializes a non-invasive, FDA-cleared oral appliance designed to treat obstructive sleep apnea (OSA). He is a seasoned healthcare entrepreneur with a proven track record of scaling and exiting successful businesses. Kirk founded Dental One, which grew into one of the largest dental service organizations (DSO) in the U.S., with over 165 practices across 15 states. After selling Dental One to MSD Capital, he led ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. He later built and exited Xenith Practices, another DSO, and founded Ortho Ventures, focusing on pediatric oral appliances. At Vivos, Kirk and his team are developing proprietary treatments for sleep-related breathing disorders, providing patients with an FDA-cleared alternative to CPAP therapy.
Caitlin Morse
Caitlin Morse is the CEO and co-founder of BrainSpace, a company focused on developing innovative medical technologies. With over a decade of experience in medtech consulting, product development, and strategic advising, Caitlin has a deep understanding of the healthcare landscape. Under her leadership, BrainSpace is working on a precision drainage system that incorporates continuous intracranial pressure (ICP) monitoring, aimed at improving the management of cerebrospinal fluid for patients recovering from strokes, traumatic brain injuries, and neurosurgery. Caitlin is known for her expertise in assessing the viability of medtech ideas and navigating the complexities of product development while balancing clinical and regulatory requirements.
Dr. Asha Parekh
Dr. Asha Parekh has a PhD in Biomedical Engineering from Western University. She combines technical expertise with entrepreneurial leadership, focusing on the development of innovative medical technologies.
Dr. Adam Power
Dr. Adam Power is an academic and practicing vascular surgeon at Western University. He has extensive training from institutions including Dalhousie, McMaster, and Mayo Clinic, and is involved in the development of medical devices aimed at improving patient outcomes.

Topics Discussed

Axena Health pelvic floor therapy Leva medtech commercialization healthcare medical device investors prostate cancer treatment Focal One robotic high-intensity focused ultrasound medical robotics scalable medtech solution clinical data credibility reimbursement early adopters partnerships Vivos Kirk Huntsman obstructive sleep apnea healthcare entrepreneur go-to-market strategy credibility markers industry partnerships IPO challenges medtech healthtech Caitlin Morse BrainSpace precision drainage system ICP monitoring cerebrospinal fluid management stroke recovery traumatic brain injuries neurosurgery medtech idea viability product development clinical demands regulatory demands Venture Capital Biomedical Engineering Medical Device Health Technology Clinical Studies Regulatory Clearance Trauma Situations Entrepreneurial Leadership

YouTube Channel

Podcast has no YouTube channel.

Instagram Profile

Podcast has no Instagram profile.

Episodes

Here's the recent few episodes on Medsider: Learn from Medtech and Healthtech Founders and CEOs.

0:00 55:01

Building the Beachhead Strategy: Interview with Axena Health Leaders Randy Pritchard and Erica Rogers

Hosts
Medsider Radio
Guests
Randy Pritchard Erica Rogers
Keywords
Axena Health pelvic floor therapy Leva medtech commercialization healthcare medical device investors

In this episode of Medsider Radio, we sat down with Randy Pritchard and Erica Rogers, leaders of Axena Health. Axena is transforming pelvic floor therapy with Leva, a device bringing clinically-proven, supervised pelvic floor muscle training into women’s homes. 

Randy, CEO of Axena, brings nearly 25 years of healthcare experience to the company, most recently as CEO of Pillar Biosciences and previously holding leadership positions at Roche Diagnostics, where he spent 18 years developing commercial expertise. Erica, who sits on Axena's Board of Directors, spent a decade as President and CEO of Silk Road Medical, leading the company from early clinical trials through IPO and eventual acquisition by Boston Scientific. A returning guest to the podcast after nearly half a decade, Erica previously held roles at Medicine360, co-founded two other medical device companies, and spent over 12 years at Boston Scientific prior to her role at Silk Road.

In this interview, they share essential medtech commercialization insights: identify your specific patient segment, build continuous clinical evidence, and communicate consistently with investors. Their experience offers invaluable lessons for medical device entrepreneurs navigating today's complex healthcare landscape.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Randy Pritchard and Erica Rogers.

0:00 1:00:47

A Great Product vs. a Great Business: Interview with EDAP TMS CEO Ryan Rhodes

Guests
Ryan Rhodes
Keywords
prostate cancer treatment Focal One robotic high-intensity focused ultrasound medical robotics scalable medtech solution clinical data credibility reimbursement early adopters

In this episode of Medsider Radio, we sat down with Ryan Rhodes, CEO of EDAP TMS. EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn’t require the use of surgery or radiation. 

Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company’s entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development.

In this interview, Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Ryan Rhodes.

0:00 1:03:36

The Hard Truth About Partnerships: Interview with Vivos CEO Kirk Huntsman

Hosts
Medsider Radio
Guests
Kirk Huntsman
Keywords
partnerships Vivos Kirk Huntsman obstructive sleep apnea healthcare entrepreneur go-to-market strategy credibility markers industry partnerships IPO challenges

In this episode of Medsider Radio, we sat down with Kirk Huntsman, CEO of Vivos, a company commercializing a non-invasive, FDA-cleared oral appliance designed to treat obstructive sleep apnea (OSA).

Kirk is a seasoned healthcare entrepreneur with a track record for scaling and exiting successful businesses. He founded Dental One, growing it into one of the largest dental service organizations (DSO) in the U.S., with over 165 practices across 15 states. After selling the company to MSD Capital, he led ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. He later built and exited Xenith Practices, another DSO, and founded Ortho Ventures, focusing on pediatric oral appliances. Now as CEO of Vivos, Kirk and his team are developing and commercializing proprietary treatments for sleep-related breathing disorders, offering patients an FDA-cleared alternative to CPAP therapy.

In this interview, Kirk talks about his go-to-market strategy, the importance of credibility markers, the complexity of industry partnerships, and the challenges he faced pursuing an IPO.


Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Kirk Huntsman.

0:00 1:01:28

Is Your Medtech Idea Worth Pursuing?: Interview with BrainSpace CEO Caitlin Morse

Guests
Caitlin Morse
Keywords
medtech healthtech Caitlin Morse BrainSpace precision drainage system ICP monitoring cerebrospinal fluid management stroke recovery traumatic brain injuries neurosurgery medtech idea viability product development clinical demands regulatory demands

In this episode of Medsider Radio, we sat down with Caitlin Morse, CEO and co-founder of BrainSpace, who has a decade of experience spanning medtech consulting, product development, and strategic advising. 

BrainSpace is developing an innovative precision drainage system with continuous ICP monitoring designed to automate cerebrospinal fluid management for patients recovering from strokes, traumatic brain injuries, and neurosurgery. 

In this interview, Caitlin shares her advice on assessing the viability of a medtech idea, tells the story of how her prototype won over stakeholders, and discusses navigating the development phase while balancing clinical and regulatory demands.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Caitlin Morse.

0:00 1:04:51

How to Succeed Without Venture Capital: Interview with Front Line Medical Co-Founders Drs. Asha Parekh and Adam Power

Hosts
Medsider Radio Host
Guests
Dr. Asha Parekh Dr. Adam Power
Keywords
Venture Capital Biomedical Engineering Medical Device Health Technology Clinical Studies Regulatory Clearance Trauma Situations Entrepreneurial Leadership

In this episode of Medsider Radio, we had an insightful discussion with Drs. Asha Parekh and Adam Power, co-founders of Front Line Medical Technologies. The company's COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) is a compact, minimally invasive device, designed for temporary aortic occlusion in trauma situations. 

Asha has a PhD in Biomedical Engineering from Western University, and combines technical expertise with entrepreneurial leadership. Adam is an academic and practicing vascular surgeon at Western University, with extensive training from institutions including Dalhousie, McMaster, and Mayo Clinic.

In this interview, they discuss how their clinical-engineer partnership accelerated development, their approach to clinical studies for regulatory clearance across multiple geographies, and their strategic decision to avoid VC funding during early development—and how that decision paid off.


Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Asha Parekh and Adam Power.

Ratings

Global:
4.7 rating 68 reviews

USA

4.7 ratings 65 reviews

UK

5.0 ratings 1 reviews

Canada

5.0 ratings 1 reviews

Australia

4.0 ratings 1 reviews

Ireland

0.0 ratings 0 reviews

New Zealand

0.0 ratings 0 reviews

Singapore

0.0 ratings 0 reviews

South Africa

0.0 ratings 0 reviews